The emerging role of MET/HGF inhibitors in oncologySCAGLIOTTI, Giorgio V; NOVELLO, Silvia; VON PAWEL, Joachim et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 793-801, issn 0305-7372, 9 p.Article

The role of topotecan in treating small cell lung cancer: second-line treatmentVON PAWEL, Joachim.Lung cancer. 2003, Vol 41, pp S3-S8, issn 0169-5002, SUP4Article

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancerMERIMSKY, Ofer; CHENG, Chi-Kin; SIU-KIE AU, Joseph et al.Oncology reports. 2012, Vol 28, Num 2, pp 721-727, issn 1021-335X, 7 p.Article

Long-term Stability of Circulating Nucleosomes in SerumHOLDENRIEDER, Stefan; VON PAWEL, Joachim; NAGEL, Dorothea et al.Anticancer research. 2010, Vol 30, Num 5, pp 1613-1615, issn 0250-7005, 3 p.Conference Paper

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide: A phase II studyRECK, Martin; JAGOS, Urzula; GRUNWALD, Franziska et al.Lung cancer. 2003, Vol 39, Num 1, pp 63-69, issn 0169-5002, 7 p.Article

Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancerHEIGENER, David F; VON PAWEL, Joachim; ESCHBACH, Corinna et al.Lung cancer. 2013, Vol 80, Num 3, pp 319-325, issn 0169-5002, 7 p.Article

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancerMANEGOLD, Christian; VANSTEENKISTE, Johan; CARDENAL, Felipe et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 175-182, issn 0167-6997, 8 p.Article

Clinical Relevance of Thymidine Kinase for the Diagnosis, Therapy Monitoring and Prognosis of Non-operable Lung CancerHOLDENRIEDER, Stefan; VON PAWEL, Joachim; DUELL, Thomas et al.Anticancer research. 2010, Vol 30, Num 5, pp 1855-1862, issn 0250-7005, 8 p.Conference Paper

Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancerHOLDENRIEDER, Stefan; STIEBER, Petra; VON PAWEL, Joachim et al.Clinical cancer research. 2004, Vol 10, Num 18, pp 5981-5987, issn 1078-0432, 7 p.Article

Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non-Small-Cell Lung CancerSCAGLIOTTI, Giorgio; NOVELLO, Silvia; AREN, Osvaldo et al.Journal of clinical oncology. 2010, Vol 28, Num 11, pp 1835-1842, issn 0732-183X, 8 p.Article

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trialBELANI, Chandra P; PEREIRA, Jose R; MILLWARD, Michael et al.Lung cancer. 2006, Vol 53, Num 2, pp 231-239, issn 0169-5002, 9 p.Article

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in Patients with small-cell lung cancerRECK, Martin; VON PAWEL, Joachim; MACHA, Hans-Nicolas et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 15, pp 1118-1127, issn 0027-8874, 10 p.Article

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung CancerSEQUIST, Lecia V; VON PAWEL, Joachim; RAMLAU, Rodryg et al.Journal of clinical oncology. 2011, Vol 29, Num 24, pp 3307-3315, issn 0732-183X, 9 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancerHOLDENRIEDER, Stefan; VON PAWEL, Joachim; RAITH, Hannelore et al.Lung cancer. 2009, Vol 63, Num 1, pp 128-135, issn 0169-5002, 8 p.Article

Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non-small-cell lung cancerJÄNNE, Pasi A; VON PAWEL, Joachim; DASSE, Kathy et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3936-3944, issn 0732-183X, 9 p.Article

A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerRECK, Martin; KRZAKOWSKI, Maciej; CHMIELOWSKA, Ewa et al.Lung cancer. 2013, Vol 82, Num 3, pp 441-448, issn 0169-5002, 8 p.Article

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non―Small-Cell Lung CancerPAZ-ARES, Luis G; BIESMA, Bonne; SYRIGOS, Kostas et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3084-3092, issn 0732-183X, 9 p.Article

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerSCAGLIOTTI, Giorgio V; GERMONPRE, Paul; BIESMA, Bonne et al.Lung cancer. 2010, Vol 68, Num 3, pp 420-426, issn 0169-5002, 7 p.Article

Symptom improvement in lung cancer patients treated with erlotinib : Quality of life analysis of the national cancer institute of canada clinical trials group study BR.21BEZJAK, Andrea; DONGSHENG TU; CYJON, Arnold et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3831-3837, issn 0732-183X, 7 p.Article

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapyHANNA, Nasser; SHEPHERD, Frances A; LIM, Hang-Liang et al.Journal of clinical oncology. 2004, Vol 22, Num 9, pp 1589-1597, issn 0732-183X, 9 p.Article

Technical performance and diagnostic utility of the new elecsys® neuron-specific enolase enzyme immunoassayMULEY, Thomas; EBERT, Werner; GURR, Eberhard et al.Clinical chemistry and laboratory medicine. 2003, Vol 41, Num 1, pp 95-103, issn 1434-6621, 9 p.Article

Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerVON PAWEL, Joachim; GATZEMEIER, Ulrich; LANE, Stephen et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1743-1749, issn 0732-183XArticle

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung CancerVANSTEENKISTE, Johan; RAMLAU, Rodryg; VON PAWEL, Joachim et al.Oncology. 2012, Vol 82, Num 1, pp 25-29, issn 0030-2414, 5 p.Article

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trialPIRKER, Robert; PEREIRA, Jose R; ROH, Jae-Kyung et al.Lancet (British edition). 2009, Vol 373, Num 9674, pp 1525-1531, issn 0140-6736, 7 p.Article